UFC middleweight Oskar Piechota will be out of action until 2022 after accepting a 22-month suspension from the United States Anti-Doping Agency after failing a drug test.
USADA officials announced the sanction on Wednesday.
“Piechota, 31, tested positive for growth hormone releasing peptide 2 (GHRP-2 or pralmorelin) and GHRP-2 (1-3) free acid, a metabolite of GHRP-2, as the result of a urine sample collected on September 25, 2020,” USADA officials said in a statement. “GHRP-2 is a Specified Substance in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics and is prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.